title: Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
abstract: In animal cells, growth factors coordinate cell proliferation and survival by regulating the phosphoinositide 3-kinase/Akt signaling pathway. Deregulation of this signaling pathway is common in a variety of human cancers. The PI3K-dependent signaling kinase complex defined as mammalian target of rapamycin complex 2 (mTORC2) functions as a regulatory Ser-473 kinase of Akt. We find that activation of mTORC2 by growth factor signaling is linked to the specific phosphorylation of its component rictor on Thr-1135. The phosphorylation of this site is induced by the growth factor stimulation and expression of the oncogenic forms of ras or PI3K. Rictor phosphorylation is sensitive to the inhibition of PI3K, mTOR, or expression of integrin-linked kinase. The substitution of wild-type rictor with its specific phospho-mutants in rictor null mouse embryonic fibroblasts did not alter the growth factor-dependent phosphorylation of Akt, indicating that the rictor Thr-1135 phosphorylation is not critical in the regulation of the mTORC2 kinase activity. We found that this rictor phosphorylation takes place in the mTORC2-deficient cells, suggesting that this modification might play a role in the regulation of not only mTORC2 but also the mTORC2-independent function of rictor.
authors.affiliation: Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Delphine
authors.initials: D
authors.lastname: Boulbes
authors.forename: Chien-Hung
authors.initials: CH
authors.lastname: Chen
authors.forename: Tattym
authors.initials: T
authors.lastname: Shaikenov
authors.forename: Nitin K
authors.initials: NK
authors.lastname: Agarwal
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Peterson
authors.forename: Terri A
authors.initials: TA
authors.lastname: Addona
authors.forename: Hasmik
authors.initials: H
authors.lastname: Keshishian
authors.forename: Steven A
authors.initials: SA
authors.lastname: Carr
authors.forename: Mark A
authors.initials: MA
authors.lastname: Magnuson
authors.forename: David M
authors.initials: DM
authors.lastname: Sabatini
authors.forename: Dos D
authors.initials: dos D
authors.lastname: Sarbassov
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D020134:Catalytic Domain / Q000235:genetics; D002460:Cell Line; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation / Q000235:genetics; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D000076226:Rapamycin-Insensitive Companion of mTOR Protein; D015398:Signal Transduction / Q000235:genetics*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*; D013912:Threonine / Q000235:genetics*
chemical_list: D002352:Carrier Proteins; D036341:Intercellular Signaling Peptides and Proteins; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D000076226:Rapamycin-Insensitive Companion of mTOR Protein; D058570:TOR Serine-Threonine Kinases; D013912:Threonine; C492571:RICTOR protein, human